Exploring and Characterizing a Novel Combination of Paeoniflorin and Talatizidine for the Treatment of Rheumatoid Arthritis
In conclusion, this study identified PAE and TLT as the main BACs of WTD in alleviating the severity of RA, and also developed a novel combination of PAE and TLT as a promising candidate drug for RA therapy.Graphical abstract
Source: Pharmacological Research - Category: Drugs & Pharmacology Source Type: research
More News: Arthritis | Drugs & Pharmacology | Genetics | Molecular Biology | Rheumatoid Arthritis | Rheumatology | Study